Pediatric Cancer Trials: Is There A Solution?

Why is it so hard to develop drugs for children with cancer? And what can be done about it? Those questions are central to a new study published in JAMA Oncology that explores new business models for funding drug development to treat pediatric cancers.

Tags:

clinical trials
2018

Frailty contributes to neurocognitive decline in young adult childhood cancer survivors

Immunotherapy Trial May Be Feasible to Combat Pediatric Pediatric Brain and Spinal Cord Tumors

Can leukemia in children with Down syndrome be prevented?

New generation anti-cancer drug shows promise for children with brain tumours

Potential Treatment May Prevent Cancer Cells From Hijacking Metabolic Pathways

Melanoma registry results shine light on rare pediatric cancer

Cancer neuroscientists identify a key culprit behind pediatric brain cancer’s spread

FDA Approves Rylaze as Alternative for Patients with ALL and Lymphoblastic Lymphoma

Why are young cancer survivors concerned about COVID-19 vaccination?

Restoring molecular clock suppresses neuroblastoma tumor growth

Search By Tags

Recent Posts